Current Pharmaceutical Design
ISSN (Print):
1381-6128
ISSN (Online):
1873-4286
Download PDF Flyer

Current Pharmaceutical Design

All Open Access articles of this journal are also available on ScienceDirect.

Impact Factor: 2.8

Indexed in: Scopus, SCI Expanded, MEDLINE/PubMed... View all

Volume 32 , Issues 42, 2026

Purchase Full Issue
Institutional Members

Volume 32, Issue 20 , 2026


Editorial

Reshaping the Future of MASLD - From Pathophysiological Mechanisms to New Therapeutic Horizons

Pp: 1537-1538
Author(s): Dimitrios Patoulias and Manfredi Rizzo
DOI: 10.2174/0113816128467087260209061251
Published on: 12 February, 2026

Review Article

Steatotic Shadows: The Dark Link Between Metabolic Dysfunction-associated Steatotic Liver Disease and Cancer Risk

Pp: 1539-1551
Author(s): Shakta Mani Satyam, Mohamed El-Tanani*, Syed Arman Rabbani, Alaa A. Aljabali, Yahia El-Tanani, Dimitrios Patoulias and Manfredi Rizzo
DOI: 10.2174/0113816128366825250307043756
Published on: 04 April, 2025

Review Article

FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical Data

Pp: 1552-1566
Author(s): Chrysoula Boutari, Achilleas Triantafyllou, Lavrentis Papalavrentios, Ioannis Goulis and Emmanouil Sinakos*
DOI: 10.2174/0113816128374854250709050425
Published on: 04 August, 2025

Review Article

Incretin-based Agents and Metabolic Dysfunction-associated Steatotic Liver Disease

Pp: 1567-1591
Author(s): Emir Muzurović*, Martin Haluzik, Ludek Horváth, Bogdan Vlacho and Didac Mauricio
DOI: 10.2174/0113816128378484250619080753
Published on: 09 July, 2025

Research Article

Nutraceutical Synergy: Unraveling the Protective Effects of Methyl Gallate and Chia Seed Oil in Doxorubicin-induced Hepatic Injury and Bax/Bcl2 Imbalance

Pp: 1592-1604
Author(s): Shakta Mani Satyam, Mohamed El-Tanani, Akheruz Zaman Ahmed, Manfredi Rizzo, Dimitrios Patoulias, Prakashchandra Shetty Kanyana*, Kalyan Chakravarthi Kosuri, Rashmi Kumari and Sainath Prabhakar
DOI: 10.2174/0113816128366802250413160625
Published on: 07 May, 2025

Mini-Review Article

Multi-Endogenous Nanoformulation for Endocannabinoid and Hormonal Modulation of Key Signaling Pathways in Resistant Hypertension

Pp: 1605-1611
Author(s): Virna Margarita Martín Gimenez, Sebastian García Menendez and Walter Manucha*
DOI: 10.2174/0113816128396666250728074858
Published on: 13 August, 2025

Research Article

Green Tea Catechins and COVID-19: Epidemiological Trends and Therapeutic Perspectives

Pp: 1612-1619
Author(s): Maksim Storozhuk*
DOI: 10.2174/0113816128412495250824132514
Published on: 01 September, 2025

Corrigendum

Corrigendum to: miRNA in Diagnosis and Therapeutics of Tuberculosis: Importance in Latent and Brain Associated Pathologies

Pp: 1620-1620
Author(s): Parul Gupta, Ravindra Kumar and Rituraj Niranjan*
DOI: 10.2174/138161283220260324094126
Published on: 24 March, 2026